BPH cause: what underpins the effectiveness of Thermobalancing therapy for men with enlarged prostate

Dr Allen's Device is effective because it tackles the cause of BPH. Dr Simon Allen's medical research on the Origin of Diseases has helped him to identify the causal root of prostate enlargement, namely capillary expansion. This new knowledge of BPH causality allowed Dr Allen to develop a treatment that terminates prostate enlargement by eliminating the focus of hypothermia in the affected area. End Quote

(1888PressRelease) January 15, 2016 - Thermobalancing therapy is unique in targeting the focus of hypothermia by precise local temperature control, which slowly reverses BPH. Other non-invasive treatments, including supplements and medications, are unable to stop the process of prostate enlargement. So before the invention of Dr Allen's Device, a surgery used to be the only effective treatment for BPH as it just cuts out the whole prostate gland or a part of it. However, a surgery, even a minimally invasive one, is a radical treatment method with inevitable side effects.

BPH treatment
Prostate enlargement does not have to be dreaded anymore. A new 2-year clinical trial shows that Benign Prostatic Hyperplasia (BPH) can be reversed non-invasively and safely with Thermobalancing therapy by using Dr Allen's Device. Invented by Dr Simon Allen in the United Kingdom, this essentially natural treatment method is backed by in-depth medical research and strict clinical tests.

In fact, Dr Allen's Device has already been used by men in 100 countries worldwide. Men find that wearing this soft belt with a special thermo-element is simple and does not interfere with their daily activities. So it makes perfect sense for men to opt for this gentle treatment option in the first instance.

Who can benefit from Thermobalancing therapy
Most men will get BPH at some point in their life. About 50% of men between the ages of 51 and 60, and up to 90% of men older than 80, suffer from BPH, according to the US National Institutes of Health. BPH is the most common prostate problem.

What to do when BPH is diagnosed
"Enlarged prostate medications should be used only at the acute stage of the disorder. Alpha-blockers, such as Finasteride (Proscar) and Dutasteride (Avodart), may cause sexual side effects, such as impotence, decreased sexual desire and retrograde ejaculation. Also, testosterone therapy suggested for libido and potency improvement often causes other health problems, including heart attack, stroke, and death from heart disease," explains Dr Allen. "Addressing these concerns, I designed a treatment method that works naturally. Thermobalancing therapy helps to reduce the size of enlarged prostate steadily and painlessly. It improves men's health and wellbeing."

What to keep in mind when opting for Dr Allen's Device
The clinical study has confirmed the effectiveness and safety of Thermobalancing therapy. It involved 248 men with BPH, 124 of whom used Dr Allen's Device exclusively as a mono-therapy. Thoroughly examined before and after the 6-month treatment period, the patients reported a significant improvement to the disturbing LUTS, while the volume of the enlarged prostate got smaller. Their treatment results compared favourably to other patients, also 124 men, in the control group, which did not receive treatment with Dr Allen's Device.

Dr Allen's Device as a new "tool" for urologists
"Urologists can now confidently resort to Thermobalancing therapy as a non-invasive physiotherapeutic treatment option for BPH," notes Professor Ivan Aghajanyan, Chief Urologist of Armenia, who has led this clinical study.

This treatment comes with requirements: Dr Allen's Device needs to be worn correctly, with the thermo-element covering the coccyx area of the lower back.

Indeed, the results of this clinical trial serve as a solid proof of effectiveness of this natural therapy for BPH. More broadly, it is also a step forward in the advancement of medical science in the field of chronic internal diseases.

Source: Allen S, Aghajanyan IG "Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device" Urol J. 2015 Nov 14;12(5):2371-6.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26571324
Full text: www.urologyjournal.org/index.php/uj/article/download/3214/1087

By: Ariana Adjani, MPhil (Oxon), Dip (Cantab), BSc (LSE)
Co-founder of Fine Treatment, inventor, patent holder and a healthy life style enthusiast

http://www.finetreatment.com

###

Visit Fine Treatment Website

space